HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, Sept. 15, 2022 (HealthDay News) -- Rapid at-home COVID tests have become less reliable with the emergence of the Omicron variant, new research suggests.
Only one of three widely used rapid antigen tests met World Health Organization (WHO) standards for accuracy, Dutch researchers report.
For the study -- published Sept. 14 in The BMJ-- they tested nearly 6,500 people with COVID symptoms who visited one of three test sites in the Netherlands between late December and early February.
All participants underwent a PCR test at the testing site. PCR tests are analyzed in a lab and look for genetic material from the SARS-CoV-2 virus, making them the gold standard for COVID testing.
Patients were then asked to take a rapid antigen test at home within three hours of their test site visit. Antigen tests look for antibodies the body produces to fight COVID. They are less accurate than PCR tests but provide immediate results.
Sensitivity fell from 87% to 81% for Flowflex; from 83% to 76% for MPBio; and from 80% to 67% for Clinitest, results showed. WHO standards require at least 80% sensitivity for a test. (Researchers noted that the observed declines were statistically significant only for Clinitest.)
Antigen tests require a person to swab their nose to test. When a throat swab was added to a nasal test, it boosted sensitivity of MPBio from 70% to 83% and Clinitest from 70% to 77%, researchers noted.
They said rapid antigen test manufacturers should consider adding a throat swab to their home kits.
In the meantime, people with COVID symptoms shouldn't trust a negative self-test result, because a false negative can't be ruled out, researchers added. Instead, folks should stick to general preventive measures to protect those around them.
The Cleveland Clinic has more about the types of COVID tests.
SOURCE: The BMJ, news release, Sept. 14, 2022
- FDA Says Rapid At-Home COVID Tests Not as Sensitive to Omicron ... ›
- Questions About COVID Home Tests? A Pharmacy Expert Has ... ›
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on September 21, 2022